India markets close in 5 hours 36 minutes
  • BSE SENSEX

    43,697.91
    -130.19 (-0.30%)
     
  • Nifty 50

    12,818.55
    -39.85 (-0.31%)
     
  • USD/INR

    73.8000
    +0.0320 (+0.04%)
     
  • Dow

    29,872.47
    -173.77 (-0.58%)
     
  • Nasdaq

    12,094.40
    +57.62 (+0.48%)
     
  • BTC-INR

    1,326,363.88
    -51,258.62 (-3.72%)
     
  • CMC Crypto 200

    350.27
    -20.24 (-5.46%)
     
  • Hang Seng

    26,672.52
    +2.77 (+0.01%)
     
  • Nikkei

    26,442.48
    +145.62 (+0.55%)
     
  • EUR/INR

    88.1258
    +0.2200 (+0.25%)
     
  • GBP/INR

    98.9367
    +0.2203 (+0.22%)
     
  • AED/INR

    20.0480
    +0.0080 (+0.04%)
     
  • INR/JPY

    1.4105
    -0.0026 (-0.18%)
     
  • SGD/INR

    55.1450
    +0.0520 (+0.09%)
     

INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against Fluidigm Corporation and Encourages Investors to Contact the Firm Before November 23, 2020

KirMcInerney LLP
·2-min read

NEW YORK, Oct. 30, 2020 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Fluidigm Corporation (“Fluidigm” or the “Company”) (NASDAQ: FLDM) securities during the period from February 7, 2019 through November 5, 2019, inclusive (the “Class Period”). Investors have until November 23, 2020 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that Fluidigm was experiencing longer sales cycles; (2) that, as a result, Fluidigm’s revenue was reasonably likely to decline; and (3) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

On August 1, 2019, Fluidigm reported second quarter 2019 revenue of $28.2 million, well below analysts’ expectations of $32 million, citing weakness in its microfluidics segment. On this news, the Company’s share price fell $4.10, or 34%, to close at $8.05 per share on August 2, 2019, thereby injuring investors. Then, on November 5, 2019, after the market closed, Fluidigm reported that third quarter 2019 revenue declined 8.5% year-over-year primarily due to mass cytometry instrument sales. On this news, the Company’s share price fell $2.60, or 51%, to close at $2.51 per share on November 6, 2019, thereby injuring investors further.

If you acquired Fluidigm securities, have information, or would like to learn more about these claims, please contact Thomas W. Elrod of Kirby McInerney at 212-371-6600, by email at investigations@kmllp.com, or by filling out this contact form, to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, and whistleblower litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney’s website: www.kmllp.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq., (212) 371-6600
investigations@kmllp.com
www.kmllp.com